Capital raised by Cadrenal Therapeutics
2 Form D filings · first filed Apr 2026 · Ponte Vedra, FL
Director
Listed on Cadrenal Therapeutics's Form D filings
Glynn Wilson is on file as Director at Cadrenal Therapeutics in Ponte Vedra, FL. Cadrenal Therapeutics has 2 Form D filings on record, $16.8M raised in total.
A first-in-class 12-lipoxygenase (12-LOX) inhibitor for heparin-induced thrombocytopenia (HIT), an immune-mediated thrombotic disorder. It is Phase 3-ready and holds FDA Orphan Drug and Fast Track designations.
